Blakeway Luke V, Tan Aimee, Peak Ian R A, Seib Kate L
Institute for Glycomics, Griffith University, Gold Coast, Queensland, Australia.
School of Medical Science, Griffith University, Gold Coast, Queensland, Australia.
Microbiology (Reading). 2017 Oct;163(10):1371-1384. doi: 10.1099/mic.0.000523. Epub 2017 Sep 12.
Moraxella catarrhalis is a human-restricted opportunistic bacterial pathogen of the respiratory mucosa. It frequently colonizes the nasopharynx asymptomatically, but is also an important causative agent of otitis media (OM) in children, and plays a significant role in acute exacerbations of chronic obstructive pulmonary disease (COPD) in adults. As the current treatment options for M. catarrhalis infection in OM and exacerbations of COPD are often ineffective, the development of an efficacious vaccine is warranted. However, no vaccine candidates for M. catarrhalis have progressed to clinical trials, and information regarding the distribution of M. catarrhalis virulence factors and vaccine candidates is inconsistent in the literature. It is largely unknown if virulence is associated with particular strains or subpopulations of M. catarrhalis, or if differences in clinical manifestation can be attributed to the heterogeneous expression of specific M. catarrhalis virulence factors in the circulating population. Further investigation of the distribution of M. catarrhalis virulence factors in the context of carriage and disease is required so that vaccine development may be targeted at relevant antigens that are conserved among disease-causing strains. The challenge of determining which of the proposed M. catarrhalis virulence factors are relevant to human disease is amplified by the lack of a standardized M. catarrhalis typing system to facilitate direct comparisons of worldwide isolates. Here we summarize and evaluate proposed relationships between M. catarrhalis subpopulations and specific virulence factors in the context of colonization and disease, as well as the current methods used to infer these associations.
卡他莫拉菌是一种人类特有的呼吸道黏膜机会性细菌病原体。它常无症状地定植于鼻咽部,但也是儿童中耳炎(OM)的重要病原体,并且在成人慢性阻塞性肺疾病(COPD)急性加重中起重要作用。由于目前针对OM中卡他莫拉菌感染和COPD加重的治疗选择往往无效,因此有必要研发一种有效的疫苗。然而,尚无卡他莫拉菌疫苗候选物进入临床试验阶段,而且关于卡他莫拉菌毒力因子和疫苗候选物分布的信息在文献中并不一致。目前很大程度上尚不清楚毒力是否与卡他莫拉菌的特定菌株或亚群相关,或者临床表现的差异是否可归因于循环群体中特定卡他莫拉菌毒力因子的异质性表达。需要在携带和疾病背景下进一步研究卡他莫拉菌毒力因子的分布,以便疫苗研发能够针对致病菌株中保守的相关抗原。由于缺乏标准化的卡他莫拉菌分型系统来促进全球分离株的直接比较,确定哪些拟议的卡他莫拉菌毒力因子与人类疾病相关的挑战更加艰巨。在此,我们总结并评估了在定植和疾病背景下卡他莫拉菌亚群与特定毒力因子之间的拟议关系,以及用于推断这些关联的当前方法。